Moneycontrol » News » Business » Earnings

Aurobindo Ph Sept '08 qtr PAT seen at Rs 286.8 Cr: Religare

Published on Wed, Oct 08, 2008 at 17:22 |  Source : Moneycontrol.com

Updated at Wed, Oct 08, 2008 at 18:33  

16110 Investors following Aurobindo Pharm. Share this News with them.
0
0
Share on Tumblr

ALSO READ

Aurobindo Pharm

BSE | NSE 25/05/12

Religare Hichens Harrison Research has come out with its earning estimates on Pharma sector for the quarter ended September 2008. According to the research firm, Aurobindo Pharma's September quarter sales is expected to go up 24.2% at Rs 13,640 million (Rs 1364 crore) on YoY basis.

The company's PAT is seen up 65.2% at Rs 2868 million (Rs 286.8 crore) on YoY basis.

  

PREVIOUS STORY

Buy TVS Motor; target Rs 43: Dolat Capital

NEXT STORY

How credit card companies are making a comeback

Trending News

Business News

Tags: Aurobindo Pharma, Religare
Google's Project Glass taken for a spin, 720p video recording showcased
Reebok execs named in Rs 870 cr fraud denied anticipatory bail "Reebok execs named in Rs 870 cr fraud denied anticipatory bail"

News

Rel Comm Q4 Cons Net Revenue Up 5% At `5,310 Cr (QoQ)

The latest earning numbers FIRST on CNBC-TV18
Videos

May 26 2012, 16:36

Mood downbeat but time to buy good values now: Citi`s Vaish

- in FII View

May 25 2012, 22:26

NHPC posts profit amid capacity addition, delay woes

- in Results Boardroom

Interviews

May 27 2012, 11:52 | Source: CNBC-TV18

Expect to maintain EBIDTA margin ahead: Wockhardt  

May 27 2012, 11:00 | Source: CNBC-TV18

e-commerce market in India: What's in store?  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window